Exchange: OTC·Updated 10:43 AM EDT

BRCTF BioArctic AB - Ordinary Shares Class B

$31.78
$3.22
(9.20%)
Today
EarningsAug 26
Mkt Cap$2.82B
Vol40.00

About BRCTF

BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors in 2003 and is headquartered in Stockholm, Sweden.
50

Neutral Sentiment

How do you feel about BRCTF?

Advertisement|Remove ads.